| abstract |
FIELD: pharmaceutical industry. SUBSTANCE: described are 2-aminoindane analogs of general formula I: wherein R 1 and R 2 are independently hydrogen, C 1 -C 8 alkyl; X is CH 2 R 3 or NHSO 2 R 4 ;y is hydrogen, NHSO 2 R 4 ,SO 2 (Ph); R 3 is NHSO 2 R 4 ,SO 2 R 4 ,CONR 1 R 2 ; R 4 is C 1 -C 8 alkyl, phenyl or phenyl substituted by CN or -CF 3 and pharmaceutically acceptable salts thereof which show activity with respect to Dopamine receptors. EFFECT: new 2-aminoindanes. 8 cl, 5 dwg, 40 ex, 1 tbl |